Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and health span in C. elegans

Steffi Jonk,Alan Nicol,Vicki Chrysostomou,Emma Lardner,Shu-Che Yu,Gustav Stalhammar,Jonathan Crowston,James Tribble,Peter Swoboda,Pete A Williams

DOI: https://doi.org/10.1101/2024.10.19.616468

2024-10-20

Abstract:Sarcopenia is the age-related degeneration of skeletal muscle, resulting in loss of skeletal muscle tone, mass, and quality. Skeletal muscle is a source of systemic metabolites and macromolecules important for neuronal health, function and healthy neuronal aging. Age-related loss of skeletal muscle might result in decreased metabolite and macromolecule availability, resulting in reduced neuronal function or increased susceptibility to unhealthy aging and neurodegenerative diseases. We aimed to identify muscle metabolite candidates that regulate healthy aging. C57BL/6J mice were aged to young adult (4 months) and old age (25 months) and skeletal muscle was collected. Age related muscle loss was confirmed by reduced muscle mass, muscle fiber degeneration, reduced myosin intensity, in addition to a metabolic shift and increased DNA damage in skeletal muscle. Using a low molecular weight enriched metabolomics protocol, we assessed the metabolic profile of skeletal muscle from young adult and old mice and identified 20 metabolites that were significantly changed in aged muscle. These candidate metabolites were tested in C. elegans assays of lifespan, health span, muscle-, and mitochondrial morphology under normal and stressed conditions. We identified four candidate metabolites (beta-alanine, 4-guanidinobutanoic acid, 4-hydroxyproline, pantothenic acid) that when supplemented in C. elegans provided robust gero- and mitochondrial protection. These candidates also affected life-, and health span in C. elegans models of amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Our findings support that aging muscle can be used to identify novel metabolite modulators of lifespan and health and may show promise for future treatments of neurodegenerative and neuromuscular disorders.

Cell Biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the identification of metabolites that may regulate lifespan and health span in age-related muscle degeneration (i.e., sarcopenia) through metabolic analysis. Specifically, the researchers focus on how the mass, function, and metabolic state of skeletal muscle change with age, and whether these changes affect the health of the nervous system and the overall aging process. By comparing skeletal muscle samples from young adult mice (4 months old) and elderly mice (25 months old), the research team aims to discover low-molecular-weight metabolites that significantly change during aging and further test the effects of these metabolites on the lifespan, health span, muscle morphology, and mitochondrial structure of nematodes (C. elegans).

The main objectives of the study include:
1. **Identifying sarcopenia-related metabolites**: Determine which metabolites undergo significant changes during aging, which may be related to the decline in muscle mass and function.
2. **Assessing the impact of metabolites on lifespan and health**: Test whether these candidate metabolites can extend lifespan, improve health status, or protect mitochondria from damage using the nematode model.
3. **Exploring potential therapeutic applications**: Investigate whether these metabolites can provide new therapeutic strategies for neurodegenerative and muscle diseases.

Through this series of studies, the authors hope to provide new perspectives on understanding the changes in muscle metabolism during aging and their impact on overall health, and to provide a theoretical basis for developing interventions for age-related diseases.